Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 NO MO lung adenocarcinoma

被引:33
|
作者
Nomori, H
Watanabe, K
Ohtsuka, T
Naruke, T
Suemasu, K
Kobayashi, T
Uno, K
机构
[1] Saiseikai Cent Hosp, Dept Thorac Surg, Minato Ku, Tokyo 1080073, Japan
[2] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan
[3] Nishidai Clin, Tokyo, Japan
来源
关键词
D O I
10.1016/j.jtcvs.2004.03.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We sought to predict lymph node metastasis and tumor invasiveness in clinical T1 N0 M0 lung adenocarcinomas, and we measured fluorodeoxyglucose uptake on positron emission tomography. Methods: Fluorodeoxyglucose positron emission tomography was performed on 44 patients with adenocarcinomas of 1 to 3 cm in size clinically staged as T1 N0 M0 before major lung resection with lymph node dissection. Fluorodeoxyglucose uptake was evaluated by using the contrast ratio between the tumor and contralateral healthy lung tissue. Lymphatic and vascular invasion within tumors, pleural involvement, and grade of histologic differentiation were examined. Results: The pathologic tumor stage was T1 N0 M0 in 36 patients, and a more advanced stage was found in 8 patients. Although all 22 adenocarcinomas with a contrast ratio of less than 0.5 in fluorodeoxyglucose uptake were pathologic T1 N0 M0 tumors, 8 (36%) of 22 with a contrast ratio of 0.5 or greater were of a more advanced stage than T1 N0 M0, with the difference being significant (P = .002). Adenocarcinomas with a contrast ratio of less than 0.5 showed less lymphatic and vascular invasion and less pleural involvement than those with a contrast ratio of 0.5 or greater (P = .006, P = .004, and P = .02, respectively). The grade of histologic differentiation was well differentiated in 19 of 22 adenocarcinomas with a contrast ratio of less than 0.5 (86%), which was a greater frequency than the 4 (18%) of 22 adenocarcinomas with a contrast ratio of 0.5 or greater (P < .001). Conclusion: Clinical T1 N0 M0 lung adenocarcinomas with a contrast ratio of less than 0.5 usually did not have lymph node metastasis, had less tumor involvement of vessels or pleura, and were more frequently well differentiated than those with a contrast ratio of 0.5 or greater. Limited lung resection could be indicated, lymph node dissection or mediastinoscopy could be reduced, or both in this type of adenocarcinoma.
引用
收藏
页码:396 / 401
页数:6
相关论文
共 44 条
  • [1] Histogram analysis of computed tomography numbers of clinical T1 NO MO lung adenocarcinoma, with special reference to lymph node metastasis and tumor invasiveness
    Nomori, H
    Ohtsuka, T
    Naruke, T
    Suemasu, K
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (05): : 1584 - 1589
  • [2] Preoperative predictors of lymph node metastasis in clinical T1 adenocarcinoma
    Nakahashi, Kenta
    Tsuuooka, Nobuo
    Hirayama, Kyo
    Matsuno, Masahiro
    Endo, Mareyuki
    Akahira, Junichi
    Taguri, Masataka
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2352 - 2360
  • [3] Lymph node metastasis and its risk factors in T1 lung adenocarcinoma
    Zhang, Wenhao
    Mu, Guang
    Huang, Jingjing
    Bian, Chengyu
    Wang, Hongchang
    Gu, Yan
    Xia, Yang
    Chen, Liang
    Yuan, Mei
    Wang, Jun
    THORACIC CANCER, 2023, 14 (30) : 2993 - 3000
  • [4] Predictors of occult lymph node metastasis in clinical T1 lung adenocarcinoma: a retrospective dual-center study
    Huang, Xiaoxin
    Huang, Xiaoxiao
    Wang, Kui
    Liu, Lijuan
    Jin, Guanqiao
    BMC PULMONARY MEDICINE, 2025, 25 (01):
  • [5] Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival
    Kim, Hyung Rae
    Seo, Minjung
    Nah, Yang Won
    Park, Hyung Woo
    Park, Seol Hoon
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (07) : 691 - 698
  • [6] Genomic profiles and immune cell infiltration landscapes for lymph node metastasis in T1 lung adenocarcinoma
    Wu, Fang
    Pan, Yue
    Hu, Chunhong
    Chen, Chen
    Liu, Wenliang
    Fan, Songqing
    Shu, Long
    Zhao, Lishu
    Fu, Yucheng
    Zhang, Sujuan
    Liu, Junqi
    Zeng, Yue
    Peng, Yurong
    Zang, Hongjing
    Deng, Chao
    Qiu, Zhenhua
    Ma, Fang
    Yu, Fenglei
    Liu, Xianling
    Liu, Lijuan
    Yang, Lingling
    Shao, Yang
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
    Wang, Xiang
    Zhao, Xingyu
    Li, Qiong
    Xia, Wei
    Peng, Zhaohui
    Zhang, Rui
    Li, Qingchu
    Jian, Junming
    Wang, Wei
    Tang, Yuguo
    Liu, Shiyuan
    Gao, Xin
    EUROPEAN RADIOLOGY, 2019, 29 (11) : 6049 - 6058
  • [8] Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
    Xiang Wang
    Xingyu Zhao
    Qiong Li
    Wei Xia
    Zhaohui Peng
    Rui Zhang
    Qingchu Li
    Junming Jian
    Wei Wang
    Yuguo Tang
    Shiyuan Liu
    Xin Gao
    European Radiology, 2019, 29 : 6049 - 6058
  • [9] Combining fluorine-18 fluorodeoxyglucose positron emission tomography and pathological risk factors to predict postoperative recurrence in stage I lung adenocarcinoma
    Hsu, Chien-Chin
    Ho, Kuo-Wei
    Chang, Yen-Hsiang
    Huang, Yung-Cheng
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (06) : 632 - 638
  • [10] Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma
    Vaarwerk, Bas
    Breunis, Willemijn B.
    Haveman, Lianne M.
    de Keizer, Bart
    Jehanno, Nina
    Borgwardt, Lise
    van Rijn, Rick R.
    van den Berg, Henk
    Cohen, Jeremie F.
    van Dalen, Elvira C.
    Merks, Johannes H. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (11):